Conditions | Yield |
---|---|
With boron trifluoride diethyl etherate at -10 - 0℃; | 93% |
With hydrogenchloride for 1h; Heating; | 52% |
With methanesulfonic acid at 50℃; for 2h; Temperature; |
11β-trimethylsiloxy-21-acetoxy-16α,17α-isopropylidenedioxy-9α-fluoro-pregna-1,4-diene-3,20-dione
B
triamcinolone acetonide
Conditions | Yield |
---|---|
With sodium carbonate In aqueous hydrofluoric acid | A 80% B n/a |
triamcinolone acetonide
Conditions | Yield |
---|---|
With hydrogen fluoride In chloroform at -40℃; | 76% |
16α-17-[(1-methylethylidene)bis(oxy)]-11β,21-dihydroxy-9-fluoro-4-ene-pregna-3,20-dione
triamcinolone acetonide
Conditions | Yield |
---|---|
With 2,3-dicyano-5,6-dichloro-p-benzoquinone In benzene for 70h; Heating; | 40% |
Conditions | Yield |
---|---|
With perchloric acid; acetone | |
With hydrogenchloride; acetone |
desonide
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 7 steps 1: pyridine 2: SOCl2; pyridine 3: aqueous HClO4; dioxane 4: potassium acetate; ethanol 5: CHCl3; HF 6: methanol.KOH 7: acetone; hydrochloric acid View Scheme |
21-acetoxy-pregna-4,9(11),16-triene-3,20-dinone
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 8 steps 1: KMnO4 2: pyridine 3: aqueous HClO4; dioxane 4: potassium acetate; ethanol / Behandeln einer Loesung des Reaktionsprodukts in Pyridin mit Acetanhydrid 5: CHCl3; HF 6: mit Hilfe von Nocardia corallina 7: methanol.KOH 8: acetone; hydrochloric acid View Scheme |
21-Acetoxy-16α,17α-dihydroxy-4,9(11)-pregnadien-3,20-dion
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 7 steps 1: pyridine 2: aqueous HClO4; dioxane 3: potassium acetate; ethanol / Behandeln einer Loesung des Reaktionsprodukts in Pyridin mit Acetanhydrid 4: CHCl3; HF 5: mit Hilfe von Nocardia corallina 6: methanol.KOH 7: acetone; hydrochloric acid View Scheme |
16α,21-diacetoxy-17-hydroxy-pregna-1,4,9(11)-triene-3,20-dione
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1: aqueous HClO4; dioxane 2: potassium acetate; ethanol 3: CHCl3; HF 4: methanol.KOH 5: acetone; hydrochloric acid View Scheme |
16α,21-diacetoxyprednisolone
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 6 steps 1: SOCl2; pyridine 2: aqueous HClO4; dioxane 3: potassium acetate; ethanol 4: CHCl3; HF 5: methanol.KOH 6: acetone; hydrochloric acid View Scheme |
Conditions | Yield |
---|---|
Multi-step reaction with 7 steps 1: SeO2 2: SOCl2; pyridine 3: aqueous HClO4; dioxane 4: potassium acetate; ethanol 5: CHCl3; HF 6: methanol.KOH 7: acetone; hydrochloric acid View Scheme |
16α,21-diacetoxy-9-bromo-11β,17-dihydroxy-pregn-4-ene-3,20-dione
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1: potassium acetate; ethanol / Behandeln einer Loesung des Reaktionsprodukts in Pyridin mit Acetanhydrid 2: CHCl3; HF 3: mit Hilfe von Nocardia corallina 4: methanol.KOH 5: acetone; hydrochloric acid View Scheme |
16α,21-diacetoxy-9-bromo-11β,17-dihydroxy-pregna-1,4-diene-3,20-dione
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: potassium acetate; ethanol 2: CHCl3; HF 3: methanol.KOH 4: acetone; hydrochloric acid View Scheme |
16α,21-diacetoxy-17-hydroxy-pregna-4,9(11)-diene-3,20-dione
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 6 steps 1: aqueous HClO4; dioxane 2: potassium acetate; ethanol / Behandeln einer Loesung des Reaktionsprodukts in Pyridin mit Acetanhydrid 3: CHCl3; HF 4: mit Hilfe von Nocardia corallina 5: methanol.KOH 6: acetone; hydrochloric acid View Scheme |
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: methanol.KOH 2: acetone; hydrochloric acid View Scheme |
16α,21-diacetoxy-9,11β-epoxy-17-hydroxy-9β-pregna-1,4-diene-3,20-dione
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: CHCl3; HF 2: methanol.KOH 3: acetone; hydrochloric acid View Scheme |
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1.1: formic acid; potassium permanganate / acetone; water / 1 h / -7 - -3 °C 2.1: hydrogen fluoride / -30 - -25 °C 2.2: -50 - -45 °C 3.1: sodium hydroxide / methanol; dichloromethane / -7 - -3 °C / Inert atmosphere View Scheme |
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1.1: hydrogen fluoride / -30 - -25 °C 1.2: -50 - -45 °C 2.1: sodium hydroxide / methanol; dichloromethane / -7 - -3 °C / Inert atmosphere View Scheme |
(11β,16α,17α)-21-acetyloxy-9-fluoro-11-hydroxy-16,17-<1-methylethylidenebis(oxy)>pregna-1,4-diene-3,20-dione
triamcinolone acetonide
Conditions | Yield |
---|---|
With sodium hydroxide In methanol; dichloromethane at -7 - -3℃; Inert atmosphere; | 43 g |
2-((10S,13S,14S)-10,13-dimethyl-3-oxo-6,7,8,10,12,13,14,15-octahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1.1: 1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione; perchloric acid / acetone / -10 - -5 °C 1.2: 33 - 37 °C 2.1: formic acid; potassium permanganate / acetone; water / 1 h / -7 - -3 °C 3.1: hydrogen fluoride / -30 - -25 °C 3.2: -50 - -45 °C 4.1: sodium hydroxide / methanol; dichloromethane / -7 - -3 °C / Inert atmosphere View Scheme | |
Multi-step reaction with 4 steps 1.1: formic acid / acetone / 0.08 h / -5 - 0 °C 1.2: 0.17 h / -5 - 0 °C 2.1: perchloric acid; 1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione / N,N-dimethyl-formamide / 2 h / -5 - 0 °C 3.1: sodium hydroxide / water; dichloromethane; methanol / 1 h / -5 - 0 °C / Inert atmosphere 4.1: hydrogen fluoride / water / 6.33 h / -40 - 0 °C View Scheme |
methanesulfonyl chloride
triamcinolone acetonide
triamcinolone acetonide mesylate
Conditions | Yield |
---|---|
With pyridine at 0℃; for 0.5h; Sealed tube; | 100% |
glutaric anhydride,
triamcinolone acetonide
Pentanedioic acid mono-[2-((4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-7,9-dioxa-pentaleno[2,1-a]phenanthren-6b-yl)-2-oxo-ethyl] ester
Conditions | Yield |
---|---|
With pyridine at 20℃; for 18h; | 83% |
With dmap In acetone at 20℃; for 0.4h; | 32% |
Conditions | Yield |
---|---|
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 0 - 20℃; for 2h; Mitsunobu reaction; | 82% |
diazomethane
succinic acid anhydride
acetic anhydride
triamcinolone acetonide
Conditions | Yield |
---|---|
Yield given. Multistep reaction. Title compound not separated from byproducts; |
Conditions | Yield |
---|---|
With pyridine 1.) reflux, 4 h, 2.) r.t., overnight; Yield given. Multistep reaction. Title compound not separated from byproducts; |
Conditions | Yield |
---|---|
With pyridine for 4h; Heating; Title compound not separated from byproducts; |
triamcinolone acetonide
A
9α-fluoro-11β-hydroxy-16α,17α-(1-methylethylidenedioxy)androsta-1,4-dien-3-one
B
9α-fluoro-17β-hydroperoxy-11β-hydroxy-16α,17α-(1-methylethylidenedioxy)androsta-1,4-dien-3-one
C
9α-fluoro-11β,21-dihydroxy-16α,17α-(1,1-dimethylmethylenedioxy)-1,5-cyclopregna-3-en-2,20-dione
Conditions | Yield |
---|---|
With oxygen; 1-dodecylthiol In acetonitrile Quantum yield; Further Variations:; Solvents; Reagents; irradiation wavelength; Irradiation; |
triamcinolone acetonide
A
9α-fluoro-11β-hydroxy-16α,17α-(1-methylethylidenedioxy)androsta-1,4-dien-3-one
B
9α-fluoro-11β,21-dihydroxy-16α,17α-(1,1-dimethylmethylenedioxy)-1,5-cyclopregna-3-en-2,20-dione
Conditions | Yield |
---|---|
In acetonitrile Quantum yield; Further Variations:; irradiation wavelength; UV-irradiation; | |
In acetonitrile for 0.666667h; Irradiation; | A 60 % Turnov. B 11 % Turnov. |
triamcinolone acetonide
9α-fluoro-17β-hydroperoxy-11β-hydroxy-16α,17α-(1-methylethylidenedioxy)androsta-1,4-dien-3-one
Conditions | Yield |
---|---|
With oxygen In isopropyl alcohol for 0.916667h; Irradiation; | 60 % Turnov. |
triamcinolone acetonide
9α-fluoro-11β,21-dihydroxy-16α,17α-(1,1-dimethylmethylenedioxy)-1,5-cyclopregna-3-en-2,20-dione
Conditions | Yield |
---|---|
In acetonitrile for 2h; Irradiation; | 70 % Turnov. |
triamcinolone acetonide
A
9α-fluoro-11β-hydroxy-16α,17α-(1-methylethylidenedioxy)androsta-1,4-dien-3-one
B
9α-fluoro-17β-hydroperoxy-11β-hydroxy-16α,17α-(1-methylethylidenedioxy)androsta-1,4-dien-3-one
Conditions | Yield |
---|---|
With phosphate-buffered saline; oxygen In methanol at 20℃; Product distribution; Quantum yield; Further Variations:; Solvents; Reagents; irradiation wavelength; Irradiation; | A 15 % Chromat. B 30 % Chromat. C 15 % Chromat. |
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1.1: 83 percent / pyridine / 18 h / 20 °C 2.1: carbonyldiimidazole / tetrahydrofuran / 4 h / 20 °C 2.2: 43 percent / DMAP / tetrahydrofuran / 96 h / 20 °C View Scheme |
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: 60 percent Turnov. / O2 / propan-2-ol / 0.92 h / Irradiation 2: 94 percent / triphenylphosphine / CH2Cl2 / 2 h View Scheme |
triamcinolone acetonide
9α-fluoro-11β-hydroxy-16α,17α-isopropylidenedioxy-17β-(methylthio)androsta-1,4-dien-3-one
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: 68 percent / K2CO3, air / methanol / 1 h 2: 1.) molecular sieves (4 Angstroem), Et3N / 1.) THF, 25 deg C, 0.5 h, 2.) THF, 90 min 3: molecular sieves (4 Angstroem) / toluene / 20 °C 4: -8 °C / Irradiation View Scheme |
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 5 steps 1: 68 percent / K2CO3, air / methanol / 1 h 2: 1.) molecular sieves (4 Angstroem), Et3N / 1.) THF, 25 deg C, 0.5 h, 2.) THF, 90 min 3: molecular sieves (4 Angstroem) / toluene / 20 °C 4: -8 °C / Irradiation 5: 16 percent / 3-chloroperoxybenzoic acid / CHCl3 / 25 °C View Scheme |
triamcinolone acetonide
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: 68 percent / K2CO3, air / methanol / 1 h 2: 1.) molecular sieves (4 Angstroem), Et3N / 1.) THF, 25 deg C, 0.5 h, 2.) THF, 90 min 3: molecular sieves (4 Angstroem) / toluene / 20 °C 4: 7 percent / CH2Cl2 / 20 °C / Irradiation View Scheme |
Reported in EPA TSCA Inventory.
1. Introduction of Triamcinolone acetonide
Triamcinolone acetonide, with the Systematic Name of (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-4b-Fluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, is one kind of white solid. For being incompatible with strong oxidizing agents, it belongs to the Product Categories which include Biochemistry; Steroids; Steroids (Others); Intermediates & Fine Chemicals; Pharmaceuticals. Besides, its Classification Code are including Adrenal Cortex Hormones; Anti-Inflammatory Agents; Drug / Therapeutic Agent; Glucocorticoid; Glucocorticoids; Hormones; Hormones, Hormone Substitutes, and Hormone Antagonists; Human Data; Immunologic Factors; Immunosuppressive agents; Mutation data; Reproductive Effect.
2. Properties of Triamcinolone acetonide
Triamcinolone acetonide has the below properties: (1)Molar Refractivity: 109.41 cm3; (2)Molar Volume: 324.8 cm3; (3)Surface Tension: 54.5 dyne/cm; (4)Density: 1.33 g/cm3; (5)Flash Point: 302.7 °C; (6)Enthalpy of Vaporization: 99.19 kJ/mol; (7)Boiling Point: 576.9 °C at 760 mmHg; (8)Vapour Pressure: 1.04E-15 mmHg at 25 °C; (9)Appearance: White Solid; (10)Melting Point: 274-278 °C (dec.).
3. Toxicity of Triamcinolone acetonide
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
man | TDLo | intramuscular | 571ug/kg (0.571mg/kg) | VASCULAR: SHOCK SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Annals of Pharmacotherpy. Vol. 28, Pg. 1310, 1994. |
mouse | LD50 | intraperitoneal | 105mg/kg (105mg/kg) | Drugs in Japan Vol. 6, Pg. 516, 1982. | |
mouse | LD50 | oral | 5gm/kg (5000mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 21, Pg. 2117, 1979. | |
mouse | LD50 | subcutaneous | 132mg/kg (132mg/kg) | Drugs in Japan Vol. 6, Pg. 516, 1982. | |
rat | LD50 | subcutaneous | 13100ug/kg (13.1mg/kg) | Drugs of the Future. Vol. 6, Pg. 44, 1981. | |
women | TDLo | parenteral | 4mg/kg (4mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION | Netherlands Journal of Medicine. Vol. 56, Pg. 12, 2000. |
Poison by subcutaneous and intraperitoneal routes. An experimental teratogen. Other experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits acrid smoke and toxic fumes of F−.
Hazard Codes: T
Risk Statements: 61
R61:May cause harm to the unborn child.
Safety Statements: 53-45
S53:Avoid exposure - obtain special instructions before use.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
WGK Germany: 3
RTECS: TU3920000
5. Use and Preparation of Triamcinolone acetonide
Aristocort acetonide can be used as adrenal cortical hormone medicines and also used in neurodermatitis, eczema, psoriasis, joint pain, bronchial asthma and other illnesses.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View